Topiramate
Product Images NDC 10544-628

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 10544-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure-topiramate (Image 01)

Chemical structure of Topiramate, showing its molecular arrangement including multiple oxygen atoms, sulfonamide group, and several methyl groups as part of the structure.*

FDA Label Image

Figure 1 (Image 02)

A line chart showing cumulative rates for time to first seizure over a period of 500 days for two doses of Topiramate, 50 mg/day and 400 mg/day. The chart compares outcomes between two groups with 234 and 236 participants respectively, illustrating seizure rates increasing over time with statistical significance noted (p = 0.0002).*

FDA Label Image

Label Graphic-25mg 90s (Image 03)

Topiramate Tablets, 25mg, package containing 90 tablets labeled for prescription use. The label includes storage instructions, manufacturer Blenheim Pharmacal, Inc., and product codes including NDC 10544-628-90. It features a barcode and QR code, with dosage directions advising to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.